Cases 3 and 9 had less than 20% myeloblasts but were diagnosed with AML due to genetic abnormalities specific to AML (RUNX1‐RUNX1T1 in case 3 and CBFβ‐MYH11 in case 9). Here, RUNX1 is linked to acute myeloid leukemia.